Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 handwiki Sirius Huang -- 1743 2022-11-30 01:40:33

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
HandWiki. Forkhead Box Protein O1 (FOXO1). Encyclopedia. Available online: https://encyclopedia.pub/entry/37348 (accessed on 25 September 2026).
HandWiki. Forkhead Box Protein O1 (FOXO1). Encyclopedia. Available at: https://encyclopedia.pub/entry/37348. Accessed September 25, 2026.
HandWiki. "Forkhead Box Protein O1 (FOXO1)" Encyclopedia, https://encyclopedia.pub/entry/37348 (accessed September 25, 2026).
HandWiki. (2022, November 30). Forkhead Box Protein O1 (FOXO1). In Encyclopedia. https://encyclopedia.pub/entry/37348
HandWiki. "Forkhead Box Protein O1 (FOXO1)." Encyclopedia. Web. 30 November, 2022.
Forkhead Box Protein O1 (FOXO1)
Edit
The content is sourced from: https://handwiki.org/wiki/Biology:FOXO1

Forkhead box protein O1 (FOXO1) also known as forkhead in rhabdomyosarcoma (FKHR) is a protein that in humans is encoded by the FOXO1 gene. FOXO1 is a transcription factor that plays important roles in regulation of gluconeogenesis and glycogenolysis by insulin signaling, and is also central to the decision for a preadipocyte to commit to adipogenesis. It is primarily regulated through phosphorylation on multiple residues; its transcriptional activity is dependent on its phosphorylation state.

glycogenolysis gluconeogenesis phosphorylation

References

  1. "The forkhead transcription factor Foxo1: a possible link between obesity and insulin resistance". Molecular Cell 11 (1): 6–8. January 2003. doi:10.1016/S1097-2765(03)00003-0. PMID 12535515.  https://dx.doi.org/10.1016%2FS1097-2765%2803%2900003-0
  2. "FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity". The Journal of Biological Chemistry 281 (29): 19881–91. July 2006. doi:10.1074/jbc.M600320200. PMID 16670091.  https://dx.doi.org/10.1074%2Fjbc.M600320200
  3. "Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction". Nature 423 (6939): 550–5. May 2003. doi:10.1038/nature01667. PMID 12754525.  https://dx.doi.org/10.1038%2Fnature01667
  4. "The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells". Gastroenterology 132 (4): 1434–46. April 2007. doi:10.1053/j.gastro.2007.01.033. PMID 17408630. https://zenodo.org/record/1187188/files/article.pdf. 
  5. "Entrez Gene: FOXO1 forkhead box O1 (rhabdomyosarcoma)". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2308. 
  6. "FOXO1 is an essential regulator of pluripotency in human embryonic stem cells". Nature Cell Biology 13 (9): 1092–9. July 2011. doi:10.1038/ncb2293. PMID 21804543.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4053529
  7. "Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice". Molecular Pharmacology 78 (5): 961–70. November 2010. doi:10.1124/mol.110.065714. PMID 20736318.  https://dx.doi.org/10.1124%2Fmol.110.065714
  8. "FoxO1 is required for the regulation of preproglucagon gene expression by insulin in pancreatic alphaTC1-9 cells". The Journal of Biological Chemistry 281 (51): 39358–69. December 2006. doi:10.1074/jbc.M605022200. PMID 17062568.  https://dx.doi.org/10.1074%2Fjbc.M605022200
  9. "Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass". Diabetes 55 (5): 1190–6. May 2006. doi:10.2337/db05-0825. PMID 16644672.  https://dx.doi.org/10.2337%2Fdb05-0825
  10. "Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion". The EMBO Journal 21 (9): 2263–71. May 2002. doi:10.1093/emboj/21.9.2263. PMID 11980723.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=125977
  11. "Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting". The Biochemical Journal 354 (Pt 3): 605–12. March 2001. doi:10.1042/0264-6021:3540605. PMID 11237865.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1221692
  12. "Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation". Proceedings of the National Academy of Sciences of the United States of America 100 (20): 11285–90. September 2003. doi:10.1073/pnas.1934283100. PMID 13679577.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=208749
  13. "FOXO transcription factors in the regulatory networks of longevity". Journal of Biochemistry 141 (6): 769–74. June 2007. doi:10.1093/jb/mvm104. PMID 17569704.  https://dx.doi.org/10.1093%2Fjb%2Fmvm104
  14. "The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression". The Journal of Clinical Investigation 108 (9): 1359–67. November 2001. doi:10.1172/JCI12876. PMID 11696581.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=209440
  15. "Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation". Proceedings of the National Academy of Sciences of the United States of America 102 (32): 11278–83. August 2005. doi:10.1073/pnas.0502738102. PMID 16076959.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1183558
  16. "SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation". Cell Metabolism 6 (2): 105–14. August 2007. doi:10.1016/j.cmet.2007.07.003. PMID 17681146.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2083635
  17. "FOXO1: a potential target for human diseases". Current Drug Targets 12 (9): 1235–44. August 2011. doi:10.2174/138945011796150280. PMID 21443466.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4591039
  18. "Death versus dedifferentiation: The molecular bases of beta cell mass reduction in type 2 diabetes". Seminars in Cell and Developmental Biology. 2019. doi:10.1016/j.semcdb.2019.12.002. PMID 31831356.  https://dx.doi.org/10.1016%2Fj.semcdb.2019.12.002
  19. "FOXO transcription factors: their clinical significance and regulation". BioMed Research International 2014: 925350. April 2014. doi:10.1155/2014/925350. PMID 24864265.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4016844
  20. "FOXO transcription factors throughout T cell biology". Nature Reviews. Immunology 12 (9): 649–61. September 2012. doi:10.1038/nri3278. PMID 22918467.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3875397
  21. "Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1". Nature Genetics 32 (2): 245–53. October 2002. doi:10.1038/ng890. PMID 12219087.  https://dx.doi.org/10.1038%2Fng890
  22. "FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue". Diabetes 58 (6): 1275–82. June 2009. doi:10.2337/db08-1001. PMID 19289458.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2682681
  23. "Molecular signaling mechanisms of renal gluconeogenesis in nondiabetic and diabetic conditions". Journal of Cellular Physiology 234 (6): 8134-8151. 2019. doi:10.1002/jcp.27598. PMID 30370538.  https://dx.doi.org/10.1002%2Fjcp.27598
  24. "Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner". Nature Medicine 17 (8): 961–7. July 2011. doi:10.1038/nm.2378. PMID 21804540.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3387563
  25. "FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures". Nature Communications 5: 4242. June 2014. doi:10.1038/ncomms5242. PMID 24979718.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4083475
  26. "Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma". Nature Genetics 5 (3): 230–5. November 1993. doi:10.1038/ng1193-230. PMID 8275086.  https://dx.doi.org/10.1038%2Fng1193-230
  27. "PAX3-FOXO1 fusion gene in rhabdomyosarcoma". Cancer Letters 270 (1): 10–8. October 2008. doi:10.1016/j.canlet.2008.03.035. PMID 18457914.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2575376
  28. "Impact of Diabetes on the Protective Role of FOXO1 in Wound Healing". Journal of Dental Research 94 (8): 1025–6. August 2015. doi:10.1177/0022034515586353. PMID 25978971.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=530387
  29. "AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR". Molecular and Cellular Biology 23 (1): 104–18. January 2003. doi:10.1128/MCB.23.1.104-118.2003. PMID 12482965.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=140652
  30. "Ligand-dependent interaction of estrogen receptor-alpha with members of the forkhead transcription factor family". The Journal of Biological Chemistry 276 (36): 33554–60. September 2001. doi:10.1074/jbc.M105555200. PMID 11435445.  https://dx.doi.org/10.1074%2Fjbc.M105555200
  31. "DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells". Proceedings of the National Academy of Sciences of the United States of America 97 (19): 10412–7. September 2000. doi:10.1073/pnas.190326997. PMID 10973497.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=27038
  32. "Interaction of FoxO1 and TSC2 induces insulin resistance through activation of the mammalian target of rapamycin/p70 S6K pathway". The Journal of Biological Chemistry 281 (52): 40242–51. December 2006. doi:10.1074/jbc.M608116200. PMID 17077083.  https://dx.doi.org/10.1074%2Fjbc.M608116200
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Biochemistry & Molecular Biology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
HandWiki
View Times: 1.6K
Entry Collection: HandWiki
Revision: 1 time (View History)
Update Date: 30 Nov 2022
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback